GB Sciences, Inc. (OTCQB: GBLX) is a plant-inspired research and biopharmaceutical drug development company whose goal is to create patented formulations of plant-based, optimized therapeutic mixtures that target a variety of medical conditions.
View Top Employees from GB Sciences, Inc| Website | http://gbsciences.com/ |
| Ticker | OTCQB:GBLX |
| Revenue | $23 million |
| Employees | 19 (14 on RocketReach) |
| Founded | 2001 |
| Address | 6450 Cameron St # 110, Las Vegas, Nevada 89118, US |
| Phone | (866) 721-0297 |
| Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Cannabis, Community and Lifestyle, Food and Beverage, Health Care, Manufacturing, Medical |
| Competitors | AltMed Enterprises, Delta 9 Cannabis Inc., Good Chemistry Nurseries, Theory Wellness, Zenabis Global Inc. |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular GB Sciences, Inc employee's phone or email?
GB Sciences, Inc Questions
The GB Sciences, Inc annual revenue was $23 million in 2024.
John Poss is the Chairman and Chief Executive Officer of GB Sciences, Inc.
14 people are employed at GB Sciences, Inc.
GB Sciences, Inc is based in Las Vegas, Nevada.
The NAICS codes for GB Sciences, Inc are [32, 32541, 325, 3254].
The SIC codes for GB Sciences, Inc are [283, 2834, 28].
Top GB Sciences, Inc Employees
-
5+5+
-
32
-
ViewZach Swarts
Interim Chief Financial Officer at GB Sciences, Inc
Las Vegas, Nevada, United States12 -
ViewZach Swarts
Interim Chief Financial Officer at GB Sciences, Inc
Las Vegas, Nevada, United States12 -
33
-
11
-
1
-
ViewDeliciously Dee
Parter With Relax With Happy Medibles at GB Sciences, Inc
Las Vegas, Nevada, United States -
Related Companies
